Alendronate Clinical Trials

• PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis
  ClinicalTrials.gov Identifier: NCT00005005 - Active, not recruiting
  Osteoporosis
  
• Comparison of Study Drug With Alendronate on How it Effects Glucocorticoid-Induced Osteoporosis
  ClinicalTrials.gov Identifier: NCT00051558 - Active, not recruiting
  Osteoporosis
  
• The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients
  ClinicalTrials.gov Identifier: NCT00061256 - Active, not recruiting
  HIV Infections
  
• Efficacy of Alendronate Versus Placebo in the Treatment of HIV-Associated Osteoporosis
  ClinicalTrials.gov Identifier: NCT00120757 - Active, not recruiting
  Osteoporosis; HIV Infections
  
• Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
  ClinicalTrials.gov Identifier: NCT00001728 - Active, not recruiting
  Polyostotic Fibrous Dysplasia
  
• Parathyroid Hormone (PTH) with Alendronate for Osteoporosis
  ClinicalTrials.gov Identifier: NCT00005006 - Active, not recruiting
  Osteoporosis
  
• Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients
  ClinicalTrials.gov Identifier: NCT00157690 - Active, not recruiting
  Cystic Fibrosis; Osteoporosis; Bone Diseases, Metabolic
  
• Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis
  ClinicalTrials.gov Identifier: NCT00004489 - Recruiting
  Osteoporosis; Cystic Fibrosis
  
• Study of Transitioning From Alendronate to Denosumab
  ClinicalTrials.gov Identifier: NCT00377819 - Active, not recruiting
  Postmenopausal Osteoporosis
  
• Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00504166 - Active, not recruiting
  Osteopenia; Osteoporosis
  
• Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients with Gaucher's Disease
  ClinicalTrials.gov Identifier: NCT00004488 - Recruiting
  Gaucher's Disease; Osteopenia
  
• Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis
  ClinicalTrials.gov Identifier: NCT00259857 - Active, not recruiting
  Osteoporosis
  
• Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Post Menopausal Women With Osteoporosis
  ClinicalTrials.gov Identifier: NCT00404820 - Active, not recruiting
  Osteoporosis
  
• EVA: Evista Alendronate Comparison
  ClinicalTrials.gov Identifier: NCT00035971 - Completed
  Osteoporosis
  
• Alendronate Osteoporosis Study
  ClinicalTrials.gov Identifier: NCT00277251 - Active, not recruiting
  Glucocorticoid-Associated Osteopenia and Osteoporosis
  
• A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.
  ClinicalTrials.gov Identifier: NCT00330460 - Active, not recruiting
  Osteoporosis; Osteopenia
  
• A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density
  ClinicalTrials.gov Identifier: NCT00293813 - Active, not recruiting
  Osteoporosis
  
• Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients?
  ClinicalTrials.gov Identifier: NCT00261625 - Not yet recruiting
  End-Stage Renal Disease; Peritoneal Dialysis; Osteoporosis
  
• The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.
  ClinicalTrials.gov Identifier: NCT00346190 - Recruiting
  Osteoporosis
  
• Treatment of Childhood Osteoporosis with Alendronate (Fosamax)
  ClinicalTrials.gov Identifier: NCT00001720 - Completed
  Osteoporosis
  
• Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00019695 - Active, not recruiting
  Stage IV Prostate Cancer; Bone Metastases; Adenocarcinoma of the Prostate; Recurrent Prostate Cancer
  
• Alendronate and/or Parathyroid Hormone for Osteoporosis
  ClinicalTrials.gov Identifier: NCT00000400 - Active, not recruiting
  Osteoporosis
  
• Effects of Zoledronic Acid Versu Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants
  ClinicalTrials.gov Identifier: NCT00580047 - Recruiting
  Renal Insufficiency
  
• The Effects of Alendronate After Cure of Primary Hyperparathyroidism
  ClinicalTrials.gov Identifier: NCT00359385 - Recruiting
  Hyperparathyroidism
  
• Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients
  ClinicalTrials.gov Identifier: NCT00136058 - Active, not recruiting
  Osteoporosis; Hip Fracture
  
• Effects of Parathyroid Hormone in Men with Osteoporosis
  ClinicalTrials.gov Identifier: NCT00000427 - Active, not recruiting
  Osteoporosis
  
• Osteoporosis Prevention With Low Dose Alendronate
  ClinicalTrials.gov Identifier: NCT00463268 - Not yet recruiting
  Osteopenia
  
• Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00395382 - Recruiting
  Vascular Calcification; Arteriosclerosis
  
• Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment
  ClinicalTrials.gov Identifier: NCT00122356 - Recruiting
  Breast Cancer
  
• A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  ClinicalTrials.gov Identifier: NCT00503113 - Recruiting
  Post-Menopausal Osteoporosis
  
• Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis
  ClinicalTrials.gov Identifier: NCT00265252 - Recruiting
  Non-Traumatic Osteonecrosis
  
• Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Heart Transplantation
  ClinicalTrials.gov Identifier: NCT00297830 - Recruiting
  Heart Transplantation; Bone Resorption
  
• Texture Analysis for Postmenopausal Osteoporosis
  ClinicalTrials.gov Identifier: NCT00145977 - Recruiting
  Osteoporosis; Osteopenia
  
• Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis
  ClinicalTrials.gov Identifier: NCT00010439 - Completed
  Osteoporosis
  
• Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss
  ClinicalTrials.gov Identifier: NCT00221312 - Recruiting
  Perimenopausal Bone Loss
  
• Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
  ClinicalTrials.gov Identifier: NCT00299572 - Not yet recruiting
  Peritoneal Dialysis
  
• Osteogenesis Imperfecta
  ClinicalTrials.gov Identifier: NCT00159419 - Recruiting
  Osteogenesis Imperfecta; Osteoporosis; Juvenile Pagets
  
• Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.
  ClinicalTrials.gov Identifier: NCT00138983 - Completed
  Rheumatoid Arthritis; Polymyalgia Rheumatica; Giant Cell Arteritis; Polymyositis; Wegener''s granulomatosis
  
• Bone Effects of Teriparatide Following Alendronate
  ClinicalTrials.gov Identifier: NCT00191893 - Completed
  Osteoporosis
  
• Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis
  ClinicalTrials.gov Identifier: NCT00000430 - Terminated
  Osteopenia; Osteoporosis
  
• Upper GI Handling of Branded vs. Generic Alendronate
  ClinicalTrials.gov Identifier: NCT00400530 - Completed
  Osteoporosis
  
• Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate
  ClinicalTrials.gov Identifier: NCT00327990 - Completed
  Osteoporosis
  
• The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss
  ClinicalTrials.gov Identifier: NCT00460057 - Completed
  Osteoporosis
  
• Pharmacokinetics of a Single 14C-Labeled Dose of Risedronate or Alendronate Followed by Once-a-Week Unlabeled Oral Dose
  ClinicalTrials.gov Identifier: NCT00577850 - Completed
  Osteopenia; Osteoporosis
  
• A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis
  ClinicalTrials.gov Identifier: NCT00389740 - Completed
  Osteoporosis, Postmenopausal
  
• A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00398606 - Completed
  Osteoporosis, Postmenopausal
  
• Osteoporosis Prevention After Heart Transplant
  ClinicalTrials.gov Identifier: NCT00000412 - Completed
  Osteoporosis; Cardiac transplantation
  
• OPTAMISE: Open-Label Study to Determine How Prior Therapy with Alendronate or Risedronate in Postmenopausal Women with Osteoporosis Influences the Clinical Effectiveness of Teriparatide
  ClinicalTrials.gov Identifier: NCT00130403 - Completed
  Osteoporosis, Postmenopausal
  
• Effects of Teriparatide in Postmenopausal Women with Osteoporosis Previously Treated with Alendronate or Raloxifene
  ClinicalTrials.gov Identifier: NCT00079924 - Completed
  Postmenopausal Osteoporosis
  
• Bone Loss in Premenopausal Women with Depression
  ClinicalTrials.gov Identifier: NCT00006180 - Completed
  Depression; Healthy; Osteopenia; Osteoporosis
  
• Prevention of Osteoporosis in Men with Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00048841 - Completed
  Prostate Cancer; Osteoporosis; Hypogonadism
  
• A Randomized Phase II Study of High Dose Ketoconazole Plus Alendronate Versus High Dose Ketoconazole in Patients with Androgen Independent Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00001802 - Completed
  Neoplasm Metastasis; Prostatic Neoplasm
  
• Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )
  ClinicalTrials.gov Identifier: NCT00236002 - Terminated
  Osteoporosis